The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
A practical guide to large-scale docking
Open accessAbstract
Structure-based docking screens of large compound libraries have become common in early drug and probe discovery. As computer efficiency has improved and compound libraries have grown, the ability to screen hundreds of millions, and even billions, of compounds has become feasible for modest-sized computer clusters. This allows the rapid and cost-effective exploration and categorization of vast chemical space into a subset enriched with potential hits for a given target. To accomplish this goal at speed, approximations are used that result in undersampling of possible configurations and inaccurate predictions of absolute binding energies. Accordingly, it is important to establish controls, as are common in other fields, to enhance the likelihood of success in spite of these challenges. Here we outline best practices and control docking calculations that help evaluate docking parameters for a given target prior to undertaking a large-scale prospective screen, with exemplification in one particular target, the melatonin receptor, where following this procedure led to direct docking hits with activities in the subnanomolar range. Additional controls are suggested to ensure specific activity for experimentally validated hit compounds. These guidelines should be useful regardless of the docking software used. Docking software described in the outlined protocol (DOCK3.7) is made freely available for academic research to explore new hits for a range of targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Within the chemoinformatics space, there are advances in computationally modeling how small molecules and proteins interact via docking.157–159”
From Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products (2024) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882 · cited 6×
“To view this fi le in a protein visualization application, they fi rst must be converted to a pdb fi le. csh $DOCKBASE/proteins/showsphere/doshowsph.csh matching_spheres.sph 1 matching_spheres.pdb Input: matching_spheres.sph Output: matching_spheres.pdb The output fi le, matching_spheres.pdb , can be visualized with the r…”
MethodInfluentialTrott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
The Cambridge Structural Database
Groom, C. R., Bruno, I. J., Lightfoot, M. P., & Ward, S. C. (2016) · Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials · doi:10.1107/s2052520616003954 · Cited by 10,297 · cited 2×
“We recently proposed a computational tool that estimates torsion strain energies based on experimentally determined torsional populations in the Cambridge Structural Dataset 129,130 Interaction patterns Speci fi c interactions to key residues are main features of promising candidates.”
MethodExtended-Connectivity Fingerprints
Rogers, D. O. W., & Hahn, M. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100050t · Cited by 7,925
Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051256o · Cited by 7,012 · cited 1×
“Visual examination can catch these strained compounds, but various tools have been developed to systematically analyze hundreds or thousands of compounds making them useful in this setting 127 – 129 .”
MethodDevelopment and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9644-8 · Cited by 6,207
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,340
Comparative Protein Structure Modeling Using Modeller
Eswar, N., Webb, B., Martı́-Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Šali, A. (2006) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0506s15 · Cited by 4,618
Comparative Protein Structure Modeling Using MODELLER
Webb, B., & Šali, A. (2016) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.3 · Cited by 4,404 · cited 1×
“Common programs used for homology modeling include Modeller 52 , Rosetta 53 , ICM 27 and I-Tasser 54 .”
Method
Research works printed but not linked: 2
- Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221–234 (2013). · DOI
- Alon, A. et al. Crystal structures of the σ 2 receptor template large-library docking for selective chemotypes active in vivo. Preprint at bioRxiv https://doi.org/10.1101/2021.04.29.441652 (2021). · DOI
Cited by
Sorted by citations
Items 201–300 of 554
Ma, W., Zhang, W., Le, Y., Shi, X., Xu, Q., Yang, X. P., Dou, Y., Wang, X., Zhou, W., Peng, W., et al. (2023) · Communications Chemistry · doi:10.1038/s42004-023-00984-5 · Cited by 11
Drug discovery: In silico dry data can bypass biological wet data?
Tognolini, M., Lodola, A., & Giorgio, C. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16266 · Cited by 10
Injectable biomimetic hybrid nanofibers for targeting cartilage in early osteoarthritis treatment
Yakufu, M., Jia, Q., Li, C., Ma, C., Zhang, P., Abudushalamu, M., Akber, S., Li, Y., Wang, L., Song, X., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.151790 · Cited by 10
Oncogenic Enhancers in Leukemia
Mulet‐Lazaro, R., & Delwel, R. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0211 · Cited by 11
From roots to codes: Applications of computer-aided drug discovery from medicinal plants
Javid, A., Fatima, A., Hamad, M., & Ahmed, M. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2024.08.033 · Cited by 10
Dong, J., & Hao, X. (2024) · BMC Chemistry · doi:10.1186/s13065-024-01362-5 · Cited by 10
Manzanilla‐Valdez, M. L., Montaño, S., Martínez‐Villaluenga, C., Zúñiga, F., Boesch, C., & Hernández‐Álvarez, A. J. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c03789 · Cited by 10
Probing the orphan receptors: Tools and directions
Franchini, L., & Orlandi, C. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.011 · Cited by 9
AlphaFold3 for Structure-guided Ligand DiscoveryPreprint
Menon, K. M., Davasam, A., Chen, G., Bryant, C., Deng, Z., Lam, B., Yang, C., Barcelos, D., Liu, F., Alon, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.04.692352 · Cited by 15
Self-citationBenchmarking ensemble docking methods in D3R Grand Challenge 4
Gan, J. L., Kumar, D., Chen, C., Taylor, B. C., Jagger, B. R., Amaro, R. E., & Lee, C. T. (2022) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-021-00433-2 · Cited by 10
Fathallah, N., Elkady, W. M., Zahran, S. A., Darwish, K. M., Elhady, S. S., & Elkhawas, Y. A. (2024) · Pharmaceuticals · doi:10.3390/ph17050656 · Cited by 9
“Overlaid timeframes at the beginning and end of the simulation run confirm orientin and reference ligand as relevant accommodations of the binding site (Figure 13).”
BackgroundIntroducing SpaceGA: A Search Tool to Accelerate Large Virtual Screenings of Combinatorial Libraries
Moesgaard, L., & Kongsted, J. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01308 · Cited by 9
Shen, Z., Chen, R., Gao, J. F., Chi, X., Zhang, Q., Bian, Q., Zhou, B., Che, J., Dai, H., & Dong, X. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01818 · Cited by 9
Schlinsog, M., Sattasathuchana, T., Xu, P., Guidez, E. B., Gilson, M. K., Potter, M. J., Gordon, M. S., & Webb, S. P. (2025) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.4c01707 · Cited by 9
Lin, X., Xia, Y., Li, Y. G., Huang, Y., Liu, S., Zhang, J., & Gao, Y. Q. (2025) · Nature Communications · doi:10.1038/s41467-025-61323-x · Cited by 10
Structure-based virtual screening of ultra-large chemical spaces: Advances and pitfalls
Sindt, F., & Rognan, D. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118576 · Cited by 13
Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle
Shard, A., Kapoor, S., Chatterjee, D. R., Chowdhury, M. G., & Das, R. (2023) · Current Drug Targets · doi:10.2174/1389450124666230330103126 · Cited by 9
Bolz, S. N., & Schroeder, M. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2239700 · Cited by 9
Grillberger, K., Cöllen, E., Trivisani, C. I., Blum, J. H., Leist, M., & Ecker, G. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713170 · Cited by 12
“Molecular docking can serve as a structure-based tool to elucidate binding modes and to prioritize ligands that are more likely to bind to the protein of interest [25].”
BackgroundLarge library docking for cannabinoid-1 receptor agonists with reduced side effectsPreprint
Tummino, T. A., Iliopoulos‐Tsoutsouvas, C., Bráz, J. M., O’Brien, E. S., Stein, R. M., Craik, V., Tran, N. K., Ganapathy, S., Liu, F., Shiimura, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.27.530254 · Cited by 9
Self-citationLang, S., Braz, N. F., Slater, M. J., & Kidley, N. J. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02582 · Cited by 12
Non-clinical investigations about cytotoxic and anti-platelet activities of gamma-terpinene
Souza, R. P., Pimentel, V. D., de Sousa, R. W. R., Sena, E. P., da Silva, A. C. A., Dittz, D., Ferreira, P. M. P., & de Oliveira, A. P. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03173-w · Cited by 8
“…Ticagrelor-RP2Y12 complex formed an unfavorable bond (represented by the red color), which compromises the stability of the complex, the overall number of bonds formed was higher than the other two molecules, which may justify target greater affinities (Dhorajiwala et al. 2019; Bender et al. 2021).”
Ranaweera, K. K. T. N., & Baik, M. (2024) · Animal Bioscience · doi:10.5713/ab.24.0291 · Cited by 8
“The suitability of the binding site in the target molecule for drug development can be assessed using bioinformatic tools such as ProteinPlus (https://proteins.plus).”
Hit identification in ultra large virtual screening: an integrative review and future challenges
Fang, Z. H., Sim, B. Y. C., Gunasinghe, K. K. J., Shabbir, S., Ginjom, I. R. H., Hwang, S. S., Lau, B. T., & Wezen, X. C. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104616 · Cited by 8
Kallert, E., Rodriguez, L. A., Husmann, J.-Å., Blatt, K., & Kersten, C. (2024) · RSC Medicinal Chemistry · doi:10.1039/d3md00696d · Cited by 8
Eguida, M., Bret, G., Sindt, F., Li, F., Chau, I., Ackloo, S. Z., Arrowsmith, C. H., Bolotokova, A., Ghiabi, P., Gibson, E., et al. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00601 · Cited by 8
Käck, H., & Sjögren, T. (2025) · Journal of Synchrotron Radiation · doi:10.1107/s1600577524012281 · Cited by 9
López-Rojas, P., Amesty, Á., Guerra-Rodríguez, M., Brito‐Casillas, Y., Guerra, B., Fernández‐Pérez, L., & Estévez‐Braun, A. (2022) · Pharmaceuticals · doi:10.3390/ph15050585 · Cited by 8
“Protein-ligand docking is an effective method commonly used to predict the binding mode and the affinity of a ligand in a protein-binding site [40,41].”
MethodCimino, P. F., Núñez, G. M., Rosado‐Abón, A., Amesty, Á., Estévez‐Braun, A., Díaz, K., Espinoza, C. L., & Iglesias‐Arteaga, M. A. (2023) · Steroids · doi:10.1016/j.steroids.2023.109248 · Cited by 8
Rapid Traversal of Ultralarge Chemical Space using Machine Learning Guided Docking ScreensPreprint
Luttens, A., de Vaca, I. C., Sparring, L., Norinder, U., & Carlsson, J. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-w3x36 · Cited by 8
Self-citationIon, D., Nițulescu, G. M., & Mihai, D. P. (2023) · Life · doi:10.3390/life13081635 · Cited by 7
“High-throughput screening campaigns rely on visual inspection of top-scoring ligands for candidate selection and mostly have success rates of approximately 20% on average after experimental validation [25].”
BackgroundKersten, C., Archambault, P., & Köhler, L. P. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00520 · Cited by 7
Caught between a ROCK and a hard place: current challenges in structure-based drug design
Pala, D., & Clark, D. E. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104106 · Cited by 8
Computational Hit Finding: An Industry Perspective
Gkeka, P., Svensson, F., Roca, C., de Groot, M. J., & Jerome, S. V. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03087 · Cited by 7
Sustained hydrogen peroxide production via MXene-functionalized supramolecular docking
Sun, J., Zhang, Y., Lu, W., Ong, W. L., Pan, X., Song, W., Li, Z., Li, Z., & Ho, G. W. (2026) · Nature Communications · doi:10.1038/s41467-026-70693-9 · Cited by 11
FASTDock: A Pipeline for Allosteric Drug Discovery
Ahmed, F., & Brooks, C. L. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00895 · Cited by 7
Developing Generalizable Scoring Functions for Molecular Docking: Challenges and Perspectives
Quiroga, R., & Villarreal, M. A. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673334469241017053508 · Cited by 12
A Putative Frizzled 7-Targeting Compound Acts as a Firefly Luciferase Inhibitor
Kinsolving, J., Grätz, L., Voss, J. H., Löw, B., Shorter, E., Jude, B., Lanner, J. T., Löber, S., Gmeiner, P., & Schulte, G. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02766 · Cited by 7
Structure-Based Discovery of Mouse Trace Amine-Associated Receptor 5 Antagonists
Nicoli, A., Weber, V., Bon, C., Steuer, A., Gustincich, S., Gainetdinov, R. R., Lang, R., Espinoza, S., & Pizio, A. D. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00755 · Cited by 9
Chen, X., Xue, B., Wahab, S., Sultan, A., Khalid, M., & Yang, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2291831 · Cited by 9
“Molecular Docking is a computational method used to predict the binding mode and affinity of a ligand (small molecule) to a receptor (protein) (Bender et al., 2021; Mo et al., 2015; Sultan et al., 2021, 2022).”
DockOpt: A Tool for Automatic Optimization of Docking Models
(2024) · doi:10.1021/acs.jcim.3c01406 · Cited by 7
“19 28 − 31 As both evaluation and optimization are essential for developing models that can reliably distinguish between binding and nonbinding compounds, 18 integrating them into these pipelines represents a crucial milestone toward automating the specialized skills of docking experts.”
InfluentialSelf-citationKilian, J., Ozenil, M., Millard, M., Fürtös, D., Schwingenschlögl-Maisetschläger, V., Hölzer, W., Wadsak, W., Hacker, M., Langer, T., & Pichler, V. (2022) · Pharmaceuticals · doi:10.3390/ph15020248 · Cited by 7
“Considering the approximate nature of docking scores and the corresponding interaction energies, compound ranking based on these metrices is insufficient [23]; instead, we visually inspected the remaining compounds and selected a set of 12 that interacted with similar residues as those predicted for 4-FBA, such as Cys…”
BackgroundGunasekaran, V., & Saraswathy, S. D. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.2.507 · Cited by 6
“The Sitemap tool’s binding site residue identification was used to generate the receptor grid in the Maestro Glide application [20].”
MethodPhytochemical Analysis and Compound Profiling of Boerhavia elegans Stem Extract Using GC–MS
AL‐Raddadi, T. M., Bahaffi, S. O. S., & Al‐Khateeb, L. A. (2025) · Analytical Science Advances · doi:10.1002/ansa.70011 · Cited by 6
“Molecular docking is used to evaluate the likelihood and compatibility of interactions between a protein and a ligand within a complex [29].”
Mehyar, N., Samman, N., Gheribi, S. A., Mashhour, A., Chan, P., Al‐Kaysi, R. O., Perlman, S. M., Boudjelal, M., & Islam, I. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110409 · Cited by 6
“Previous studies have attributed such discrepancies to inherent limitations in docking simulations, especially when modeling large, solvent-exposed active sites (45).”
Das, A., Debnath, S., Maurya, A. P., Singha, L. P., Das, N., & Pandey, P. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.140338 · Cited by 6
Toward generalizable predictive models for DNA-encoded libraries
Poongavanam, V., Turunen, S. P., Sandberg, K., Yngve, U., & Wannberg, J. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104629 · Cited by 6
On drug discovery against infectious diseases and academic medicinal chemistry contributions
Janin, Y. L. (2022) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.18.141 · Cited by 6
Ferreira, N. C. D. S., Viviani, L. G., Lima, L. M., do Amaral, A. T., Romano, J. V. P., Fortunato, A. L., Soares, R. F., Alberto, A. V. P., Neto, J. A. C., & Alves, L. A. (2024) · Pharmaceuticals · doi:10.3390/ph17050592 · Cited by 6
“Docking is frequently used, alone or in combination with other in silico approaches, as part of VS protocols [36–38].”
BackgroundMethodInfluentialOptical control of cell-surface and endomembrane-exclusive β-adrenergic receptor signaling
Thotamune, W., Ubeysinghe, S., Shrestha, K. K., Mostafa, M. E., Young, M. C., & Karunarathne, A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107481 · Cited by 6
“Then they were docked into the glide grid generated to examine their binding to the receptor in silico (70).”
Shevtsova, T. V., Iduoku, K., Patnode, K., Olabode, I., Casañola‐Martín, G. M., Rasulev, B., & Voronov, A. S. (2024) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.4c03971 · Cited by 6
Wang, C., Zhang, S., Shao, Z., Sun, P., Zhang, J., Zhang, S., Kong, J., Hong, Z., Li, L., Li, M., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.177905 · Cited by 6
Yu, W., Weber, D. J., & MacKerell, A. D. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c01814 · Cited by 6
Islam, S. I., Ahmed, S. S., Mahfuj, S., Das, G., Tareq, M. M. I., Almehmadi, M. M., Allahyani, M. A., Alsiwiehri, N. O., Biswas, P., Hasan, M. N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-82043-0 · Cited by 6
FP-MAP: an extensive library of fingerprint-based molecular activity prediction tools
Venkatraman, V. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1239467 · Cited by 5
“However, despite recent efforts (Gorgulla et al., 2020; Bender et al., 2021; Glaser et al., 2021; Gentile et al., 2022; Luttens et al., 2022) reliable simulationmethods for large scale activity prediction still remain elusive.”
BackgroundDakpa, G., Kumar, K. J. S., Nelen, J., Pérez‐Sánchez, H., & Wang, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-44476-x · Cited by 6
Fifty years of pain research and clinical advances: highlights and key trends
Basbaum, A. I., Jensen, T. S., & Keefe, F. J. (2023) · Pain · doi:10.1097/j.pain.0000000000003058 · Cited by 6
Virtual Screening in Search for a Chemical Probe for Angiotensin-Converting Enzyme 2 (ACE2)
Kravets, I. O., Dudenko, D., Pashenko, A. E., Borisova, Т., Tolstanova, G. M., Ryabukhin, S. V., & Volochnyuk, D. M. (2021) · Molecules · doi:10.3390/molecules26247584 · Cited by 6
“[24] This part of the work aims to develop and test the workflow for a medium-sized library for resource intensity, to further elaborate an effective approach to large-scale docking, in our case for the screening of the Enamine REAL database set (1.”
BackgroundMethodSrivastava, M., Singh, K., Kumar, S., Hasan, S. M., Mujeeb, S., Kushwaha, S. P., & Husen, A. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575287322240115115125 · Cited by 5
Al-Mahrami, N., Nair, S. S. K., Al‐Mawali, A., Shafreen, R. B., Ullah, S. M., Halim, S. A., Al‐Harrasi, A., & Sivakumar, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39649 · Cited by 5
Graham, J. G., Bisson, J. I., Harris, G. H., Wang, Z. J., Waller, D. P., & Pauli, G. F. (2024) · Journal of Natural Products · doi:10.1021/acs.jnatprod.4c00439 · Cited by 5
Large Library Docking and Biophysical Analysis of Small-Molecule TMPRSS2 Inhibitors
Fraser, B. J., Young, N. J., Bender, B. J., Gahbauer, S., Ilyassov, O., Wilson, R. P., Li, Y., Seitova, A., Lourenço, A. L., Chung, D. H., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03089 · Cited by 5
Self-citationLießmann, F., Eisenhuth, P., Fürll, A., Vu, O., Moretti, R., & Meiler, J. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01084-3 · Cited by 7
“In recent years, there has been an explosion of computer-aided screening methods, driven by the integration of advanced computational techniques, artificial intelligence (AI), and machine learning (ML) [3–6].”
Kushwah, R., Jain, S., Sahu, M., Chinchu Praisthy, L. J., Maurya, S., Ansari, T., Mansi, Mishra, A. K., & Kuznetsov, A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04814-4 · Cited by 5
Mayasich, S. A., Goldsmith, M. R., Mattingly, K. Z., & LaLone, C. A. (2023) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5591 · Cited by 5
“…targets with holo crystal structures (with bound ligands) than apo structures like that for the DIO3, and virtual screening may have greater utility in eliminating inactive (nonbinding) compounds from further consideration than in ranking between inhibitors of similar potency (Bender et al., 2021).”
BackgroundShahab, M., Zulfat, M., & Zheng, G. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2275174 · Cited by 5
“To determine the optimum binding configuration, these configurations have been assessed using scoring methods (Bender et al., 2021; McNutt et al., 2021).”
Tran, X.-T. D., Phan, T.-L., To, V.-T., Tran, N.-V. N., Nguyen, N.-N. S., Nguyen, D.-N. H., Tran, N.-T. N., & Truong, T. N. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1382319 · Cited by 5
Antitumor effect of a new human epidermal growth factor receptor inhibitor
Kit, O. I., Kodonidi, I. P., Frantsiyants, E. M., Kaplieva, I. V., Glushko, A. A., Trepitaki, L. K., Surikova, E. I., Bandovkina, V. A., Pogorelova, Y. A., Neskubina, I. V., et al. (2024) · Research and Practical Medicine Journal · doi:10.17709/2410-1893-2024-11-3-4 · Cited by 5
Computational design of potent dimeric phenylthiazole NS5A inhibitors for hepatitis C virus
Liman, W., Oubahmane, M., Lahcen, N. A., Hdoufane, I., Cherqaoui, D., Daoud, R., & Allali, A. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-80082-1 · Cited by 5
Shi, D., Pang, Q., Qin, Q., Yao, X., Yao, X., & Yu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1026306 · Cited by 5
“Since the high false positive rate is always a big problem in virtual screening (Adeshina et al., 2020; Bender et al., 2021), other strategies were also designed to ensure the reliability of virtual screening during the whole process, including the evaluation of docking and screening abilities, structural diversity an…”
BackgroundIntegration of molecular modelling and in vitro studies to inhibit LexA proteolysis
Schuurs, Z. P., McDonald, J. P., Croft, L. V., Richard, D. J., Woodgate, R., & Gandhi, N. S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1051602 · Cited by 6
“These approaches have also facilitated the ability to screen large chemical spaces in a relatively short amount of time and at little cost compared to their counterpart in vitro screening techniques (Bender et al., 2021).”
BackgroundKumar, V., Singh, P., Parate, S., Singh, R., Ro, H., Song, K. S., Lee, K. W., & Park, Y. (2024) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2024.108789 · Cited by 5
CBD Versus CBDP: Comparing In Vitro Receptor-Binding Activities
Haghdoost, M., Young, S., Holloway, A. K., Roberts, M., Zvorsky, I. A., & Bonn‐Miller, M. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147724 · Cited by 5
Xu, M., Xiao, X., Chen, Y., Zhou, X., Parisi, L., & Ma, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35769 · Cited by 5
Conev, A., Chen, J., & Kavraki, L. E. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169163 · Cited by 5
“Molecular docking is a common computational approach for modeling protein-ligand interactions and is used to assist structure-based drug discovery [1].”
warpDOCK: Large-Scale Virtual Drug Discovery Using Cloud Infrastructure
McDougal, D. P., Rajapaksha, H., Pederick, J. L., & Bruning, J. B. (2023) · ACS Omega · doi:10.1021/acsomega.3c02249 · Cited by 6
Li, J., Zhao, K., Yang, G., Lv, H., Zhang, R., Li, S., Chen, Z., Xu, M., Yang, N., & Dai, S. (2025) · Molecules · doi:10.3390/molecules30122653 · Cited by 4
“To address this, molecular docking is planned to explore potential drug targets [77], although detailed experimental validation will be required for more reliable insights.”
Locusts adopt IP 3 as a second messenger for olfactory signal transduction
Yang, J., He, H., Dong, S., Lv, J., Cheng, L., Yu, Q., Kang, L., & Guo, X. (2025) · Science Advances · doi:10.1126/sciadv.ads1352 · Cited by 4
Colibăşanu, D., Groza, V., Occhiuzzi, M. A., Grande, F., Udrescu, M., & Udrescu, L. (2025) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2025.1666716 · Cited by 4
“However, molecular docking requires significant computational resources, and applying it on a large scale is cumbersome Bender et al. (2021).”
Pérez-Sánchez, L. E., Ayala-Guerrero, L. M., Mendieta‐Moctezuma, A., Villalobos-López, M. Á., & Ríos-Meléndez, S. (2026) · Plants · doi:10.3390/plants15020193 · Cited by 5
“Crucially, they are also used to estimate ADMET profiles (Absorption, Distribution, Metabolism, Excretion, Toxicity), which are fundamental for prioritization and do not replace bioassays [70].”
Kumar, M., Anusha, P., Mukhopadhyay, S., Chowdhury, S., Phalak, M., Devi, U., & Shukla, P. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340107 · Cited by 4
“While molecular docking offers a useful initial screening of protein–ligand interactions, it has inherent limitations due to simplified scoring functions and static models [54].”
VsNsbench: evaluating AlphaFold3-embed induced-fit mechanism for enhanced virtual screening
Gu, S., Shen, C. Q., Yang, Y., Zhai, S.-L., Li, J., Tian, Y.-N., Zhang, X., Du, H., Wu, Z., Wang, X., et al. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01732-2 · Cited by 4
“Notably, the choice of protein structure signi fi cantly in fl uences screening ef fi cacy, as evidenced by the superior enrichment capability of experimentally determined holo structures (bound to speci fi c ligands) compared to their apo -form counterparts (ligand free) [4, 5].”
Tariq, M. R., Wang, H., Liu, S., Armenia, I., Tettamanti, G., Korai, S. K., Lin, H., Zheng, C., Liang, Y., Qin, J., et al. (2026) · Insects · doi:10.3390/insects17020207 · Cited by 4
Integrating Hydrogen Exchange with Molecular Dynamics for Improved Ligand Binding Predictions
Walters, B. T., Patapoff, A. W., Kiefer, J. R., Wu, P., & Wang, W. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c00397 · Cited by 4
Leveraging computer-aided drug design for the discovery of phytohormone analogs: A review
Guo, Y., Qanmber, G., Liu, Z., Yang, H., Li, J., Yang, Z., Li, Z., Yang, L., & Yang, L. (2025) · Plant Stress · doi:10.1016/j.stress.2025.100951 · Cited by 4
Gyebi, G. A., & Sabiu, S. (2025) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2025.128617 · Cited by 4
Wang, J., Fang, X., Yang, J., Tang, Q., Yang, Y., Li, Z., Zhang, F., Wu, Q., Luo, Z., & Zheng, Z. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.135385 · Cited by 4
Darvesh, S., Cash, M. K., Forrestall, K. L., Maillet, H., & Sands, D. C. (2025) · Aging · doi:10.18632/aging.206227 · Cited by 4
“Crystal structures for human AChE (Protein Databank code (PDB): 4M0E, 2.00 Å resolution) [91] and BChE (PDB: 4TPK, 2.70 Å) [92] were obtained from the Protein Databank [146] and were selected based on resolution and co-crystallization properties deemed appropriate for molecular docking [100].”
InfluentialMteremko, D., Chilongola, J. O., Paluch, A. S., & Chacha, M. N. (2022) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2022.108348 · Cited by 4
Zhu, H., Sharafi, M., Teh, W. P., Bratt, A. S., Buhrlage, S. J., & Marto, J. A. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202200113 · Cited by 4
Allosteric modulators of solute carrier function: a theoretical framework
Boytsov, D., Schicker, K. W., Hellsberg, E., Freissmuth, M., & Sandtner, W. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1166450 · Cited by 4
“, several G protein-coupled receptors (Orry et al., 2006; Kolb et al., 2009; Kolb and Irwin, 2009; Katritch et al., 2011; Rognan, 2011; Gabrielsen et al., 2012; Kufareva et al., 2012; Gabrielsen et al., 2013; Ngo et al., 2016; Rognan, 2017; Roth et al., 2017; Scharf et al., 2019; Alon et al., 2021; Ballante et al., 20…”
BackgroundXi, L., Shi, A., Shen, T., Wang, G., Wei, Y., & Guo, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1197856 · Cited by 4
Achieving the promise and avoiding the peril of chemical probes using genetics
Jones, N. H., & Kapoor, T. M. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102628 · Cited by 4
Molecular Docking in Drug Designing and Metabolism
Saikia, S., Puzari, M., & Chetia, P. (2023) · Springer eBooks · doi:10.1007/978-981-99-2816-3_14 · Cited by 4
Vieira, R., de Sousa, K. A., da Silva, G. S., Silva, D. H. S., & Castro‐Gamboa, I. (2023) · Expert Systems with Applications · doi:10.1016/j.eswa.2023.121178 · Cited by 4
Galdino, G. T., Mailhot, O., & Najmanovich, R. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00788 · Cited by 3
Structure-Based Discovery of a NPFF1R Antagonist with Analgesic ActivityPreprint
Bender, B. J., Pickett, J. E., Bráz, J. M., Kang, H. J., Gahbauer, S., Bhardwaj, K., Rodriguez-Rosado, S., Liu, Y., Jain, M. K., Basbaum, A. I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.25.564029 · Cited by 5
“A final set of well-performing models was selected for a screen with the known ligands embedded in a library of about 1 million monocations selected from the larger library 14,27 .”
BackgroundMethodInfluentialSelf-citationWills, S., Sánchez-García, R., Roughley, S. D., Merritt, A. T., Hubbard, R. E., von Delft, F., & Deane, C. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.02.606367 · Cited by 4
“Thus, early exploration of chemical space is important, enabling a comprehensive understanding of the structure–activity relationship (SAR) and of which substructures are required for (or will ablate) binding [20, 21].”
BackgroundSong, R. X.-D., Nicklaus, M. C., & Tarasova, N. I. (2024) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-024-00562-4 · Cited by 3
“Screening of virtual libraries of synthesizable compounds has become an increasingly important step in drug discovery [1, 2].”
BackgroundLee, D., Hwang, W., Byun, J., & Shin, B. (2024) · BMC Bioinformatics · doi:10.1186/s12859-024-05923-2 · Cited by 3
Metadata
- Authors
- Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., & Shoichet, B. K.
- Affiliations
- University of California, San Francisco (US)
- Uppsala University (SE)
- Frederick National Laboratory for Cancer Research (US)
- Corresponding author
- Shoichet, Brian K.
- ORCID
- Venue
- Nature Protocols
- Published
- 2021-09-24
- Volume
- 16
- Issue
- 10
- Pages
- 4799-4832
- ISSN
- 1750-2799 (ISSN-L)
- 1754-2189
- PMC
- PMC8522653
- OpenAlex
- W3201539868
- Cited by
- 546
- References
- 145
- Citations by year
- 2026: 96 · 2025: 123 · 2024: 140 · 2023: 117 · 2022: 66 · 2021: 4
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-12-09)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Protocols (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Mental Health (R01MH112205)
- National Institute on Drug Abuse (R37DA045657)
- National Institute of General Medical Sciences (T32GM008284, R01GM133836, F32GM136062, T32GM007175, R35GM122481)
- National Institute of Diabetes and Digestive and Kidney Diseases (U24DK116195)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- structure-based virtual screening, binding energy prediction, melatonin receptors, hit identification, cluster computing, drug discovery
- MeSH terms
- Ligands, Software, Drug Design, Drug Discovery, Molecular Docking Simulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review